| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — | — | — | — | 42,1 k € | — | 54,2 k € | -8.8% | 59,4 k € | — | — | — | |||||||||||||||||
| Gross margin | 10,4 k € | -48.9% | 20,4 k € | +935.9% | 2,0 k € | +120.3% | -9,7 k € | -150.8% | 19,1 k € | +44.4% | 13,2 k € | -18.4% | 16,2 k € | -48.3% | 31,3 k € | +33.2% | 23,5 k € | -67.7% | 72,8 k € | +605.4% | -14,4 k € | +66.9% | -43,5 k € | -14.9% | -37,9 k € | +9.6% | -41,9 k € | -100.5% | -20,9 k € | -120.1% | 104,1 k € | +246.3% | 30,0 k € | +462.9% | -8,3 k € | |
| EBITDA | 8,8 k € | -51.6% | 18,2 k € | +825.1% | 2,0 k € | +120.3% | -9,7 k € | -150.8% | 19,1 k € | +14643.0% | 129,6 € | -99.2% | 16,2 k € | -47.5% | 30,9 k € | +35.9% | 22,7 k € | -68.7% | 72,7 k € | +592.6% | -14,7 k € | +66.5% | -44,0 k € | -14.6% | -38,4 k € | +21.0% | -48,6 k € | -116.1% | -22,5 k € | -122.5% | 99,9 k € | +257.0% | 28,0 k € | +328.2% | -12,3 k € | |
| Operating profit | -6,0 k € | -604.6% | 1,2 k € | +109.7% | -12,3 k € | +10.0% | -13,6 k € | -110.7% | -6,5 k € | +74.2% | -25,1 k € | -238.8% | -7,4 k € | -234.8% | 5,5 k € | +232.7% | -4,1 k € | -107.9% | 52,3 k € | +366.3% | -19,6 k € | +62.7% | -52,6 k € | -17.9% | -44,6 k € | +18.2% | -54,6 k € | -59.5% | -34,2 k € | -137.2% | 91,9 k € | +241.9% | 26,9 k € | +291.6% | -14,0 k € | |
| Profit/loss | 2,6 k € | -71.4% | 9,1 k € | +237.5% | -6,6 k € | +22.0% | -8,5 k € | -294.5% | -2,2 k € | +90.0% | -21,5 k € | -1154.8% | 2,0 k € | -84.7% | 13,4 k € | +2661.7% | 483,9 € | -99.2% | 57,4 k € | +222.0% | -47,0 k € | -1.7% | -46,2 k € | +71.2% | -160,3 k € | -207.3% | -52,2 k € | -66.2% | -31,4 k € | +92.8% | -438,7 k € | -11953.1% | -3,6 k € | +86.7% | -27,3 k € | |
| Equity | 191,9 k € | +1.4% | 189,3 k € | +5.1% | 180,2 k € | -3.6% | 186,8 k € | -4.4% | 195,3 k € | -1.1% | 197,5 k € | -9.8% | 219,0 k € | +0.9% | 217,0 k € | +6.6% | 203,6 k € | +0.2% | 203,1 k € | +101.6% | 100,8 k € | -31.8% | 147,8 k € | -23.8% | 194,1 k € | -45.2% | 354,4 k € | -12.8% | 406,5 k € | -7.2% | 437,9 k € | -50.0% | 876,6 k € | -0.4% | 880,2 k € | |
| Total assets | 261,7 k € | +2.9% | 254,5 k € | -1.0% | 257,1 k € | +0.3% | 256,4 k € | -2.3% | 262,5 k € | +4.4% | 251,4 k € | +7.6% | 233,6 k € | -9.1% | 257,0 k € | +0.1% | 256,9 k € | +8.9% | 235,9 k € | +51.5% | 155,7 k € | -6.0% | 165,6 k € | -29.9% | 236,2 k € | -37.5% | 377,7 k € | -13.1% | 434,7 k € | -7.6% | 470,3 k € | -69.8% | 1,6 M € | +1.9% | 1,5 M € | |
| Cash | 739,5 € | +22.7% | 602,9 € | +330.9% | 139,9 € | -97.1% | 4,8 k € | +16.1% | 4,2 k € | +2955.0% | 136,8 € | — | — | — | 15,4 k € | +1211.6% | 1,2 k € | -64.4% | 3,3 k € | — | — | — | 14,1 k € | +148.6% | 5,7 k € | +474.0% | 988,5 € | |||||||||
| Debts | 21,3 k € | +27.8% | 16,7 k € | -41.3% | 28,4 k € | +23.3% | 23,1 k € | +54.6% | 14,9 k € | +14.2% | 13,1 k € | -10.4% | 14,6 k € | -63.6% | 40,0 k € | -24.8% | 53,2 k € | +62.2% | 32,8 k € | -40.3% | 54,9 k € | +209.0% | 17,8 k € | -57.9% | 42,2 k € | +81.8% | 23,2 k € | -17.7% | 28,2 k € | -12.9% | 32,4 k € | -94.8% | 623,3 k € | +0.6% | 619,7 k € | |
Public limited company · Ixelles · incorporated on 15/12/1986
Public limited company profitable and well capitalised. Cash position rising (+22.7%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
NO HEADACHE is a Public limited company incorporated in 1986. Its main activity is: Manufacture of basic pharmaceutical products. Its registered office is in Ixelles.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette